Dr. Pradeep Natarajan, MD
Not yet claimedPreventive cardiologist, Cardiologist, Lipidologist · Physician (MD)
Boston, MA
Director of Preventive Cardiology and the Paul and Phyllis Fireman Endowed Chair in Vascular Medicine at Massachusetts General Hospital and Associate Professor at Harvard Medical School; he uses germline and somatic genetics to uncover new biology and improve care for cardiovascular disease.
About Dr. Pradeep Natarajan, MD
Updated Sep 20, 2026 · next review Dec 19, 2026Dr. Pradeep Natarajan is a preventive cardiologist and cardiovascular geneticist in Boston. He is Director of Preventive Cardiology at Massachusetts General Hospital and holds the Paul & Phyllis Fireman Endowed Chair in Vascular Medicine. He also leads the MGH Cardiovascular Disease Prevention Center, which covers prevention, genetics, and cardiac rehabilitation programs.
His training includes a BA from the University of California, Berkeley, an MD from the University of California, San Francisco, and a master of medical sciences in biomedical informatics from Harvard Medical School. He did his internal medicine residency at Brigham and Women's Hospital and his cardiovascular medicine fellowship at Massachusetts General Hospital, followed by postdoctoral training in human genetics at MGH and the Broad Institute.
Beyond patient care, he serves as Associate Director of Personalized Medicine at Mass General Brigham and teaches at Harvard Medical School and the Harvard T.H. Chan School of Public Health. He is a Fellow of the American College of Cardiology and the American Heart Association, an elected member of the American Society for Clinical Investigation and the Association of American Physicians, and received the American Heart Association's 2023 Joseph A. Vita Award. His lab site notes he contributed to a multi-society ACC/AHA guideline on managing dyslipidemia (cholesterol and blood fats).
Open Payments records from CMS show he received $83,472.57 from industry across 18 records between 2021 and 2025, with the largest amounts from Genentech ($56,515), Esperion Therapeutics ($6,440), Novartis ($5,587), Eli Lilly ($4,528), and AstraZeneca UK ($3,222). Payments from drug and device companies to physicians are common and legal, and are often tied to research or consulting work.
- Director of Preventive Cardiology
- He directs Preventive Cardiology at Massachusetts General Hospital and holds the Paul & Phyllis Fireman Endowed Chair in Vascular Medicine. massgeneral.org
- Leads prevention center
- He leads the MGH Cardiovascular Disease Prevention Center, overseeing prevention, genetics, and cardiac rehabilitation programs. massgeneralbrigham.org
- Cholesterol guideline contributor
- His lab site states he contributed to the multi-society ACC/AHA Guideline on the Management of Dyslipidemia published in Circulation. His specific committee role was not stated in the sources reviewed. natarajanlab.mgh.harvard.edu
- Training at UCSF, Brigham, MGH
- MD from the University of California, San Francisco (2008), internal medicine residency at Brigham and Women's Hospital (2011), and cardiovascular medicine fellowship at Massachusetts General Hospital (2015). cvrc.massgeneral.org
- Genetics research background
- He completed postdoctoral training in human genetics at MGH and the Broad Institute of Harvard & MIT, and earned a master's in biomedical informatics at Harvard Medical School in 2015. researchers.mgh.harvard.edu
- Society fellowships and honors
- He is a Fellow of the American College of Cardiology and the American Heart Association, and an elected member of the American Society for Clinical Investigation and the Association of American Physicians. natarajanlab.mgh.harvard.edu
- 2023 AHA Vita Award
- He received the 2023 Joseph A. Vita Award from the American Heart Association, presented at the AHA Scientific Sessions in November 2023. natarajanlab.mgh.harvard.edu
- Faculty and leadership roles
- He is Associate Director of Personalized Medicine at Mass General Brigham, Associate Professor of Medicine at Harvard Medical School, Associate Professor of Epidemiology at the Harvard T.H. Chan School of Public Health, and an Associate Member of the Broad Institute. professional.heart.org
- Industry payments on record
- CMS Open Payments lists $83,472.57 across 18 records from 2021 to 2025, with the largest total from Genentech ($56,515). openpaymentsdata.cms.gov
Worth knowing
- Board certification could not be confirmed from an ABIM or ABMS certificate record in the research performed. Hospital and directory pages list him as a cardiologist. Patients can verify certification at certificationmatters.org. certificationmatters.org
Industry payments (CMS Open Payments)
Open the CMS recordFederal law requires drug and device companies to report what they pay clinicians: meals, travel, speaking, consulting, and research. Payments are common and legal; the point is that you can see them.
2021 to 2025
$83,473
18 payments
| 2021 | $26,647 |
| 2022 | $31,205 |
| 2023 | $7,853 |
| 2024 | $16,635 |
| 2025 | $1,133 |
Top payers
- Genentech, Inc.$56,515
- Esperion Therapeutics, Inc.$6,440
- NOVARTIS PHARMACEUTICALS CORPORATION$5,587
- Eli Lilly and Company$4,528
- AstraZeneca UK Limited$3,222
Payment types
- Consulting Fee$83,412
- Food and Beverage$61
A word of caution about these numbers
A payment does not mean your doctor is compromised or acting unethically. Most of these entries are drug samples left for patients, or lunch brought in for the office staff, and the amounts are usually small. Research funding and speaking at medical meetings are also normal parts of a clinical career.
As a rough guide, a total under $15,000 a year is usually not a concern. Much larger sums, especially from one company whose product your doctor recommends to you, are worth asking about. You are allowed to ask.
Sources: natarajanlab.mgh.harvard.edu · massgeneral.org · massgeneralbrigham.org · doctors.massgeneralbrigham.org · cvrc.massgeneral.org · researchers.mgh.harvard.edu · massgeneral.org · x.com. Something wrong or out of date? Tell us and we will correct it.
Summary prepared with AI assistance from the public sources linked above, reviewed every three months. It is not a review, a rating, or an endorsement.
Practice location
Mass General Brigham Preventive Cardiology Clinic at the Corrigan Minehan Heart Center
25 New Chardon Street
Boston, MA 02114
Open in maps